Table 4:
Changes of the Cx43 gene expressions in the control, PCOS, and POR groups
| Groups | CX432^−Δ ΔCt | P-value1 | P-value2 | P-value3 | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| N | Mean | SD | Median | ||||
| Control (N without treatment) | 3 | 1.000 | 0.000 | 1.000 | |||
| Control (N-Isop) | 3 | 0.638 | 0.024 | 0.649 | 0.037a | ||
| Control (N-Prop) | 3 | 1.013 | 0.023 | 1.012 | 0.487a | ||
| PCOS without treatment | 3 | 0.345 | 0.033 | 0.347 | 0.037a | ||
| PCOS-Isop | 3 | 0.211 | 0.032 | 0.207 | 0.049b | 0.049 | |
| PCOS-Prop | 3 | 0.489 | 0.015 | 0.496 | 0.049c | 0.049 | |
| POR without treatment | 3 | 0.313 | 0.017 | 0.309 | 0.037a | ||
| POR-Isop | 3 | 0.007 | 0.001 | 0.007 | 0.049b | 0.049 | |
| POR-Prop | 3 | 0.505 | 0.017 | 0.515 | 0.049c | 0.049 | |
P-value1: -a: In comparison with Non-PCOs without treatment group. b: In comparison with Control Isoproterenol group. c: In comparison with Non-PCOs Propranolol group.
P-value2: : In comparison with PCOs without treatment
P-value3: : In comparison with POR without treatment group
All comparison were done with Mann-Whitney test